Dystrobrevins in muscle and non-muscle tissues

Neuromuscular Disorders

Volumn 17, Issue 2, 2007, Pages 123-134

  Rees, Melissa L J ^a   Lien, Chun Fu ^a   Górecki, Dariusz C ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Dystrobrevin binding proteins; Dystrobrevins; Muscular dystrophy

Indexed keywords

ALPHA DYSTROBREVIN; BETA DYSTOBREVIN; BINDING PROTEIN; DESMUSLIN; DYSBINDIN; DYSTROBREVIN; DYSTROPHIN ASSOCIATED PROTEIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG;

BARTH SYNDROME; BEHAVIOR DISORDER; BIPOLAR DISORDER; BRAIN; COGNITIVE DEFECT; DEVELOPMENT; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MOTOR DYSFUNCTION; MUSCLE; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; OCULAR ALBINISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA;

ANIMALS; DYSTROPHIN-ASSOCIATED PROTEINS; HUMANS; MICE; MODELS, MOLECULAR; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PROTEIN BINDING;

EID: 33847020706     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2006.11.003     Document Type: Review

References (141)

1. Rando T.A. The dystrophin-glycoprotein complex, cellular signalling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 24 (2001) 1575-1594
2. Kandel E.R., Schwartz J.H., and Jessel T.M. Principles of neural science. 3rd ed. (1991), Appleton and Lange p. 252
3. Anderson J.L., Head S.I., Rae C., and Morley J.W. Brain function in Duchenne muscular dystrophy. Brain 125 (2002) 4-13
4. Zatz M., de Paula F., Starling A., and Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscular Disorders 13 (2003) 532-544
5. Muntoni F., and Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscular Disorders 14 (2004) 635-649
6. Guglieri M., Magri F., and Comi G.P. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities. Clin Chim Acta 361 (2005) 54-79
7. Cohn R.D. Dystroglycan: important player in skeletal muscle and beyond. Neuromuscular Disorders 15 (2005) 207-217
8. Lovering R.M., Porter N.C., and Bloch R.J. The muscular dystrophies: from genes to therapies. Phys Therapy 85 (2005) 1372-1388
9. van der Maarel SM, Frants RR, Padberg GW. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta (BBA), 2006 Jun 6: [Epub ahead of print].
10. Yoshida M., Suzuki A., Yamamoto H., Noguchi S., Mizuno Y., and Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-d-glucoside. Eur J Biochem 222 (1994) 1055-1061
11. Blake D.J., Hawkes R., Bensom M.A., and Beesley P.W. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol 147 (1999) 645-658
12. Loh N.Y., Nebenius-Oosthuizen D., Blake D.J., Smith A.J., and Davies K.E. Role of beta-dystrobrevin in nonmuscle dystrophin-associated protein complex-like complexes in kidney and liver. Mol Cell Biol 21 (2001) 7442-7448
13. Haenggi T., Soontornmalai A., Schaub M.C., and Fritschy J.M. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience 129 (2004) 403-413
14. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122 (1993) 809-823
15. Bowe M.A., Deyst K.A., Leszyk J.D., and Fallon J.R. Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 12 (1994) 1173-1180
16. Peng H.B., Ali A.A., Daggett D.F., Rauvala H., Hassell J.R., and Smalheiser N.R. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Communun 5 (1998) 475-489
17. Sugita S., Saito F., Tang J., Satz J., Campbell K., and Sudhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154 (2001) 435-445
18. Jung D., Yang B., Meyer J., Chamberlain J.S., and Campbell K.P. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270 (1995) 27305-27310
19. Rentschler S., Linn H., Deininger K., Bedford M.T., Espanel X., and Sudol M. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. Biol Chem 380 (1999) 431-442
20. Sadoulet-Puccio H.M., Khurana T.S., Cohen J.B., and Kunkel L.M. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Human Mol Genet 5 (1996) 489-496
21. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., and Blake D.J. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276 (2001) 24232-24241
22. Newey S.E., Howman E.V., Ponting C.P., et al. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem 276 (2001) 6645-6655
23. Mizuno Y., Thompson T.G., Guyon J.R., et al. Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci 98 (2001) 6156-6161
24. Albrecht D.E., and Froehner S.C. DAMAGE, a novel alpha-dystrobrevin-associated MAGE protein in dystrophin complexes. J Biol Chem 279 (2004) 7014-7023
25. Yoshida M., Hama H., Ishikawa-Sakurai M., et al. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Human Mol Genet 9 (2000) 1033-1040
26. Adams M.E., Butler M.H., Dwyer T.M., Peters M.F., Murnane A.A., and Froehner S.C. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11 (1993) 531-540
27. Ahn A.H., Freener C.A., Gussoni E., Yoshida M., Ozawa E., and Kunkel L.M. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 271 (1996) 2724-2730
28. Ahn A.H., Yoshida M., Anderson M.S., et al. Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24. Proc Natl Acad Sci USA 10 (1994) 4446-4450
29. Piluso G., Mirabella M., Ricci E., et al. Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem 275 (2000) 15851-15860
30. Alessi A., Bragg A.D., Percival J.M., et al. γ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins. Exp Cell Res 312 (2006) 3084-3095
31. Compton A.G., Cooper S.T., Hill P.M., Yang N., Froehner S.C., and North K.N. The syntrophin-dystrobrevin subcomplex in human neuromuscular disorders. J Neuropathol Exp Neurol 64 (2005) 350-361
32. Newey S.E., Benson M.A., Ponting C.P., Davies K.E., and Blake D.J. Alternative splicing of dystrobrevin regulated the stoichiometry of syntrophin binding to the dystrophin protein complex. Curr Biol 10 (2000) 1295-1298
33. Adams M.E., Mueller H.A., and Froehner S.C. In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol 155 (2001) 113-122
34. Hasegawa M., Cuenda A., Spillantini M.G., et al. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. J Biol Chem 274 (1999) 12626-12631
35. Gee S.H., Madhavan R., Levinson S.R., Caldwell J.H., Sealock R., and Froehner S.C. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci 18 (1998) 128-137
36. Lumeng C., Phelps S., Crawford G.E., Walden P.D., Barald K., and Chamberlain J.S. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 2 (1999) 611-617
37. Chen Z., Hague C., Hall R.A., and Minneman K.P. Syntrophins regulate alpha1D-adrenergic recptors through a PDZ domain-mediated interaction. J Biol Chem 281 (2006) 12414-12420
38. Neely J.D., Amiry-Moghaddam M., Ottersen O.P., Froehner S.C., Agre P., and Adams M.E. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci USA 98 (2001) 14108-14113
39. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., and Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345 (1990) 315-319
40. Ohlendieck K., and Campbell K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115 (1991) 1685-1694
41. Ohlendieck K., Matsumura K., Ionasescu V.V., et al. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43 (1993) 795-800
42. Matsumura K., Yamada H., Shimizu T., and Campbell K.P. Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett 334 (1993) 281-285
43. Greenberg D.S., Schatz Y., Levy Z., Pizzo P., Yaffe D., and Nudel U. Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. Human Mol Genet 5 (1996) 1299-1303
44. O'Brien K.F., and Kunkel L.M. Dystrophin and muscular dystrophy: past, present, and future. Mol Genet Metabol 74 (2001) 75-88
45. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
46. Voisin V., Sebrie C., Matecki S., et al. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol Disorders 20 (2005) 123-130
47. Muntoni F., Torelli S., and Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 12 (2003) 731-740
48. Kimura S., Ito K., Miyagi T., et al. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy. Brain Dev 27 (2005) 400-405
49. Negroni E., Butler-Browne G.S., and Mouly V. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle. Pathologie Biologie 54 (2006) 100-108
50. Angelini C. Advances and perspectives in muscular dystrophies. Basic Appl Myol 12 (2002) 17-25
51. Williamson R.A., Henry M.D., Daniels K.J., et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Human Mol Genet 6 (1997) 831-841
52. Martin P.T. The dystroglycanopathies: the new disorders of O-linked glycosylation. Semin Pediatric Neurol 12 (2005) 152-158
53. Mercado M.L., Amenta A.R., Hagiwara H., et al. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J 20 (2006) 1724-1726
54. Carr C., Fischbach G.D., and Cohen J.B. A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle. J Cell Biol 109 (1989) 1753-1764
55. Blake D.J., Nawrotzki R., Peters M.F., Froehner S.C., and Davies K.E. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 271 (1996) 7802-7810
56. Peters M.F., O'Brien K.F., Sadoulet-Puccio H.M., and Kunkel L.M. Adams ME, Froehner SC. J Biol Chem 272 (1997) 31561-31569
57. Loh N.Y., Ambrose H.J., Guay-Woodford L.M., et al. Genomic organization and refined mapping of the mouse beta-dystrobrevin gene. Mammal Genome 9 (1998) 857-862
58. Wagner K.R., and Huganir R.L. Tyrosine and serine phosphorylation of dystrophin and the 58-kDa protein in the postsynaptic membrane of Torpedo electric organ. J Neurochem 62 (1994) 1947-1952
59. Grady R.M., Akaaboune M., Cohen A.L., Maimone M.M., Lichtman J.W., and Sanes J.R. Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions. J Cell Biol 160 (2003) 741-752
60. NCBI website [online]. Available from: http://www.ncbi.nlm.nih.gov [accessed 16.02.06].
61. Peters M.F., Sadoulet-Puccio H.M., Grady R.M., et al. Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Biol Chem 142 (1998) 1269-1278
62. Holzfeind P.J., Ambrose H.J., Newey S.E., Nawrotzki R.A., Blake D.J., and Davies K.E. Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters. J Biol Chem 274 (1999) 6250-6258
63. Blake D.J., Mawrotzki R., Loh N.Y., Górecki D.C., and Davies K.E. Beta-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci 95 (1998) 241-246
64. Nawrotzki R., Loh N.Y., Ruegg M.A., Davies K.E., and Blake D.J. Characterisation of alpha-dystrobrevin in muscle. J Cell Sci 111 (1998) 2595-2605
65. Ceccarini M., Macioce P., Panetta B., and Petrucci T.C. Expression of dystrophin-associated proteins during neuronal differentiation of P19 embryonal carcinoma cells. Neuromuscular Disorders 12 (2002) 36-48
66. Lien C.F., Vlachouli C., Blake D.J., Simons J.P., and Górecki D.C. Differential spatio-temporal expression of alpha-dystrobrevin-1 during mouse development. Gene Express Patterns 4 (2004) 583-593
67. Grady R.M., Zhou H., Cunningham J.M., Henry M.D., Campbell K.P., and Sanes J.R. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25 (2000) 279-293
68. Lien C.F., Hazai D., Yeung D., et al. Expression of alpha-dystrobrevin in blood-tissue barriers: sub-cellular localisation and molecular characterisation in normal and dystrophic mice. Cell Tissue Res (2006) [Epub ahead of print]
69. Grady R.M., Merlie J.P., and Sanes J.R. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 136 (1997) 871-882
70. Haenggi T., Schaub M.C., and Fritschy J.M. Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 319 (2005) 299-313
71. Haenggi T., and Fritschy J.M. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 63 (2006) 1614-1631
72. Deconinck A.E., Rafael J.A., Skinner J.A., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90 (1997) 717-727
73. Blake D.J. Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?. Neuromuscular Disorders 12 (2002) S110-S117
74. Xue Z.G., Cheraud Y., Brocheriou V., et al. The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res 298 (2004) 431-444
75. Banwell B.L. Intermediate filament-related myopathies. Pediatric Neurol 24 (2001) 257-263
76. Howman E.V., Sullivan N., Poon E.P., Britton J.E., Hilton-Jones D., and Davies K.E. Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscular Disorders 13 (2003) 42-48
77. Li W., Zhang Q., Oiso N., et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-relared organelles complex 1 (BLOC-1). Nat Genet 35 (2003) 84-89
78. Nazarian R., Starcevic M., Spencer M.J., and Dell'Angelica E.C. Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosomes-related organelles complex-1) as a dystrobrevin-binding protein. Biochem J 395 (2006) 587-598
79. Bhosle R.C., Michele D.E., Campbell K.P., Li Z., and Robson R.M. Interactions of intermediate filament protein synemin with dystrophin and utrophin. Biochem Biophys Res Commun 346 (2006) 768-777
80. Jones K.J., Compton A.G., Yang N., et al. Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy. Neuromuscular Disorders 13 (2003) 456-467
81. Ishikawa H., Nonaka I., and Nishino I. Negative result in search for human alpha-dystrobrevin deficiency. Muscle and Nerve 28 (2003) 387-388
82. Ichida F., Tsubata S., Bowles K.R., et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103 (2001) 1256-1263
83. Xing Y., Ichida F., Matsuoka T., et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogenity. Mol Genet Metabol 88 (2006) 71-77
84. Kurowski M.A., and Bujnicki J.M. GeneSilico protein structure prediction metaserver. Nucl Acids Res 31 (2003) 3305-3307
85. Kenton A.B., Sanchez X., Coveler K.J., et al. Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alpha-dystrobrevin and FK binding protein-12. Mol Genet Metabol 82 (2004) 162-166
86. Kanemoto N., Horigome H., Nakayama J., et al. Interstitial 1q43-q43 deletion with left ventricular noncompaction myocardium. Eur J Med Genet 49 (2006) 247-253
87. Johnson M.T., Zhang S., Gilkeson R., et al. Intrafamilial variability of noncompaction of the ventricular myocardium. Am Heart J 151 (2006) 1012-1014
88. Hwang J.J., Allen P.D., Tseng G.C., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10 (2002) 31-44
89. Straub R.E., Jiang Y., MacLean C.J., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Human Genet 71 (2002) 337-348
90. Schwab S.G., Knapp M., Mondabon S., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Human Genet 72 (2003) 185-190
91. Van Den Bogaert A., Schumacher J., Schulze T.G., et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Human Genet 73 (2003) 1438-1443
92. Tang J.X., Zhou J., Fan J.B., et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 8 (2003) 717-718
93. van den Oord E.J., Sullivan P.F., Jiang Y., et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry (2003) 499-510
94. Funke B., Finn C.T., Plocik A.M., et al. Association of the DTNBP1 locus with schizophrenia in a US population. Am J Human Genet 75 (2004) 891-898
95. Kirov G., Ivanov D., Williams N.M., et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 55 (2004) 971-975
96. Numakawa T., Yagasaki Y., Ishimoto T., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Human Mol Genet 13 (2004) 2699-2708
97. Williams N.M., Preece A., Morris D.W., et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 61 (2004) 336-344
98. Bray N.J., Preece A., Williams N.M., et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Human Mol Genet 14 (2005) 1947-1954
99. Kumamoto N., Matsuzaki S., Inoue K., et al. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun 345 (2006) 904-909
100. Hanson D.R., Gottesman I.I., and Heston L.L. Some possible childhood indicators of adult schizophrenia inferred from children of schizophrenics. Br J Psychiatry 129 (1976) 142-154
101. Breen G., Prata D., Osborne S., Munro J., Sinclair M., Li T., et al. Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry 163 (2006) 1636-1638
102. Donohoe G., Morris D.W., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia (2006) [Epub ahead of print]
103. Joo E.J., Lee K.Y., Jeong S.H., Ahn Y.M., Koo Y.J., and Kim Y.S. The dysbindin gene (DTNBP1) and schizophrenia: No support for an association in the Korean population. Neurosci Lett 407 (2006) 101-106
104. Holliday E.G., Handoko H.Y., James M.R., McGrath J.J., Nertney D.A., Tirupati S., et al. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res Human Genet 9 (2006) 531-539
105. Tochigi M., Zhang X., Ohashi J., Hibino H., Otowa T., Rogers M., et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 56 (2006) 154-158
106. Weickert C.S., Straub R.E., McClintock B.W., et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61 (2004) 544-555
107. Talbot K., Eidem W.L., Tinsley C.L., et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Investig 113 (2004) 1353-1363
108. Grady R.M., Wozniak D.F., Ohlemiller K.K., and Sanes J.R. Cerebellar synaptic defects and abnormal motor behaviour in mice lacking alpha- and beta-dystrobrevin. J Neurosci 26 (2006) 2841-2851
109. Numakawa T., Yagasaki Y., Ishimoto T., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Human Mol Genet 13 (2004) 2699-2708
110. Kumamoto N., Matsuzaki S., Inoue K., et al. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun 345 (2006) 904-909
111. Laruelle M., Frankle W.G., Narendran R., et al. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Therapeut 27 (2005) AS16-AS24
112. Tuominen H.J., Tiihonen J., and Wahlbeck K. Glutamatergic drugs for schizophrenia. Cochrane Database Syst Rev 19 (2006) CD003737
113. Starcevic M., and Dell'Angelica E.C. Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem 279 (2004) 28393-28401
114. Di Pietro S.M., Falcon-Pérez J.M., Tenza D., et al. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol Biol Cell 17 (2006) 4027-4028
115. Holt K.H., Lim L.E., Straub V., et al. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. Mol Cell 1 (1998) 841-848
116. Grady R.M., Grange R.W., Lau K.S., et al. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1 (1999) 215-220
117. Sanes J.R., Apel E.D., Burgess R.W., et al. Development of the neuromuscular junction: genetic analysis in mice. J Physiol, Paris 92 (1998) 167-172
118. Hoch W. Formation of the neuromuscular junction: Agrin and its unusual receptors. Eur J Biochem/FEBS 265 (1999) 1-10
119. Banks G.B., Fuhrer C., Adams M.E., and Froehner S.C. The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex. J Neurocytol 32 (2003) 709-726
120. Wells K.E., Torelli S., Lu Q., Brown S.C., Partridge T., Muntoni F., et al. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscular Disorders 13 (2003) 21-31
121. Chang W.J., Iannaccone S.T., Lau K.S., Master B.S.S., McCabe T.J., and McMillan K. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci 93 (1996) 9142-9147
122. Sander M. Functional muscle ischemia in neuronal nitric oxide synthase deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci 97 (2000) 13818-13823
123. Sogos V., Reali C., Fanni V., Curto M., and Gremo F. Dystrophin antisense oligonucleotides decrease expression of nNOS in human neurons. Mol Brain Res 118 (2003) 52-59
124. Chao D.S., Silvagno F., and Bredt D.S. Muscular dystrophy in mdx mouse despite lack of neuronal nitric oxide synthase. J Neurochem 71 (1998) 784-789
125. Urch C.E., and Dickenson A.H. Neuronal nitric oxide synthase modulation of dorsal horn neuronal responses in the rat: a developmental study. Dev Neurosci 25 (2003) 301-307
126. Chao D.S., Gorospe J.R., Brenman J.E., et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184 (1996) 606-618
127. Wells K.E., Fletcher S., Mann C.J., et al. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett 552 (2003) 145-149
128. Levi S., Grady R.M., Henry M.D., Campbell K.P., Sanes J.R., and Craig A.M. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci 22 (2002) 4274-4285
129. Macioce P., Gambara G., Bernassola M., et al. β-Dystrobrevin interacts directly with kinesin heavy chain in brain. J Cell Sci 116 (2003) 4847-4856
130. Ceccarini M., Torreri P., Lombardi D.G., Macchia G., Macioce P., and Petrucci T.C. Molecular basis of dystrobrevin interaction with kinesin heavy chain: structural determinants of their binding. J Mol Biol 4 (2005) 872-882
131. Miller K.E., DeProto J., Kaufmann N., Patel B.N., Duckworth A., and Van Vactor D. Direct observation demonstrates that Liprin-alpha is required for trafficking of synaptic vesicles. Curr Biol 15 (2005) 684-689
132. Sakamoto R., Byrd D.T., Brown H.M., Hisamoto N., Matsumoto K., and Jin Y. The Caenorhabditis elegans UNC-14 RUN domain protein binds to the kinesin-1 and UNC-16 complex and regulates synaptic vesicle localization. Mol Biol Cell 16 (2005) 483-496
133. Brickley K., Smith M.J., Beck M., and Stephenson F.A. GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J Biol Chem 280 (2005) 14723-14732
134. Miki H., Setou M., Kaneshiro K., and Hirokawa N. All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci 98 (2001) 7004-7011
135. Setou M., Seog D.H., Tanaka Y., et al. Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature 417 (2002) 83-87
136. A receptor-associated protein, GRIF-1. J Biol Chem 277 (2002) 30079-30090
137. Ceccarini M., Torreri P., Bernassola M., Macchia G., Macioce P., and Petrucci T.C. A coiled-coil interaction mediates the formation of a ternary complex between dystrophin. Dystrobrevin and kinesin heavy chain: Possible implications in the mechanisms of transport. J Physiol, Paris 99 (2006) 1
138. Helliwell T.R., Man N.T., Morris G.E., et al. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibers in dystrophies and inflammatory myopathies. Neuromuscular Disorders 2 (1992) 177-184
139. Karpati G., Carpenter S., Morris G.E., et al. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 52 (1993) 119-128
140. Pons F., Robert A., Fabbrizio E., et al. Utrophin localization in normal and dystrophin-deficient heart. Circulation 90 (1994) 369-374
141. Sewry C.A., Matsumura K., Campbell K.P., et al. Expression of dystrophin-associated glycoproteins and utrophin in carriers of Duchenne muscular dystrophy. Neuromuscular Disorders 4 (1994) 401-409